Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma.

Find People
Find Everything
About This Site
Edit My Profile
Export RDF
Login to Profiles

Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma.

Bylow KA, Atkins MB, Posadas EM, Stadler WM, McDermott DF. Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma. Clin Genitourin Cancer. 2009 Jan; 7(1):39-42.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Papillary
Carcinoma, Renal Cell
Female
Humans
Kidney Neoplasms
Male
Middle Aged
Paclitaxel
Prognosis
Survival Rate
Treatment Outcome

authors with profiles

Walter M. Stadler